Literature DB >> 8527492

Reversion of malignant phenotype by 5-iodo-6-amino-1,2-benzopyrone a non-covalently binding ligand of poly(ADP-ribose) polymerase.

P I Bauer1, E Kirsten, G Varadi, L J Young, A Hakam, J A Comstock, E Kun.   

Abstract

A non-covalently binding inhibitory ligand of poly(ADP-ribose) polymerase, 5-iodo-6-amino-1,2-benzopyrone, when incubated at 5-600 microM external concentration with an E-ras-transformed tumorigenic cell line or with human prostatic carcinoma cells for 40 to 60 days converts both cancer cells to a non-tumorigenic phenotype that is characterized by drastic changes in cell morphology, absence of tumorigenicity in nude mice, and a high rate of aerobic glycolysis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8527492     DOI: 10.1016/0300-9084(96)88149-1

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  3 in total

1.  Syncytiotrophoblastic giant cells in teratocarcinoma-like tumors derived from Parp-disrupted mouse embryonic stem cells.

Authors:  T Nozaki; M Masutani; M Watanabe; T Ochiya; F Hasegawa; H Nakagama; H Suzuki; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  Protection against peroxynitrite-induced fibroblast injury and arthritis development by inhibition of poly(ADP-ribose) synthase.

Authors:  C Szabó; L Virág; S Cuzzocrea; G S Scott; P Hake; M P O'Connor; B Zingarelli; A Salzman; E Kun
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

3.  Insights into the binding of PARP inhibitors to the catalytic domain of human tankyrase-2.

Authors:  Wei Qiu; Robert Lam; Oleksandr Voytyuk; Vladimir Romanov; Roni Gordon; Simon Gebremeskel; Jakub Vodsedalek; Christine Thompson; Irina Beletskaya; Kevin P Battaile; Emil F Pai; Robert Rottapel; Nickolay Y Chirgadze
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.